|

Alzheimer's Disease Clinical Trials in San Antonio, TX

12 recruiting studies within 50 miles

Phase
Trial Phase Dist.
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)Phase 3<1 mi
Advancing Alzheimer's Care: Home-based tDCS for Affective SymptomsN/A<1 mi
Trial-Ready Cohort-Down Syndrome (TRC-DS)—<1 mi
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's DementiaPhase 2<1 mi
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)Phase 3<1 mi
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's DiseasePhase 2<1 mi
Rapamycin - Effects on Alzheimer's and Cognitive HealthPhase 2<1 mi
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)Phase 3<1 mi
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)Phase 3<1 mi
δ in Dementia Clinical TrialsN/A<1 mi
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)Phase 1/2<1 mi
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 PhaseN/A46 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.